VBI Vaccines Inc. New (Canada) (VBIV) Financials

$0.02

$-- (--%)

As on 06-Sep-2024 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$9 Mln

P/E Ratio

--

P/B Ratio

1.2

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-60.88	-73.70	-39.91	-47.05	-48.71
Cash Flow from Investing Activities	--	--	-4.34	23.16	-26.00	-3.67
Cash from Financing Activities	--	22.70	19.45	44.29	122.39	37.42
Net Cash Inflow / Outflow	--	--	-58.59	27.54	49.34	-14.97

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-104.93	-96.52	-39.85	-32.38	-51.85
ROE (%)	--	-258.99	-135.50	-46.04	-36.38	-59.88
ROA (%)	-53.35	-76.71	-77.16	-34.62	-28.52	-42.96
EBIT Margin (%)	-423.00	-637.08	-7,561.92	-10,781.62	-4,110.93	-2,083.69
Net Margin (%)	-2,396.33	-1,069.29	534.03	-1,994.78	-4,090.48	-2,786.07
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	553.09	7.02	0.71	-0.41	-0.52	-0.34
EBIT Growth (%)	51.28	32.40	-20.27	-55.98	5.75	22.10
Net Profit Growth (%)	31.98	34.14	-94.01	-53.64	15.27	12.26
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.24	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.69	-0.55	0.13	1.36	2.43	0.64
Close Price ($)	0.60	0.59	11.73	70.20	82.50	41.40
High Price ($)	10.47	21.00	74.10	144.90	207.90	66.00
Low Price ($)	0.45	0.45	10.80	62.70	20.70	13.97
Market Cap ($ Cr)	1.87	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	7.05	0.81	0.22	0.10	0.17
Short term debt to equity ratio	-9.07	6.87	0.02	0.01	0.01	0.17
Current Ratio	0.34	0.48	2.10	4.00	7.61	1.58
Quick Ratio	0.21	0.37	1.92	3.92	7.49	1.54
Interest Coverage	-10.16	-6.86	-20.42	-14.38	-16.11	-21.07

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	18.44	14.60	8.69	1.27	7.26	9.05
Asset Turnover	0.06	0.07	0.01	0.00	0.01	0.02
Receivable days	--	28.65	17.22	24.60	47.85	21.13
Inventory Days	--	190.20	148.60	80.17	64.28	45.89
Payable days	--	244.44	279.43	135.89	96.83	165.94
Cash Conversion Cycle	--	-25.60	-113.61	-31.12	15.30	-98.92

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.